Literature DB >> 12136058

Long-term prognosis after recovery from primary intracerebral hemorrhage.

S E Vermeer1, A Algra, C L Franke, P J Koudstaal, G J E Rinkel.   

Abstract

BACKGROUND: Little is known about the long-term outcome for patients who recover from a primary intracerebral hemorrhage. The authors examined the rate of recurrence, vascular events, and death in survivors of a primary intracerebral hemorrhage and the factors related to the long-term prognosis.
METHODS: All 243 patients admitted to one of three hospitals with a primary intracerebral hemorrhage who regained independence were interviewed about vascular events after the index hemorrhage. The authors used the Kaplan-Meier method to estimate the event-free survival and Cox proportional hazards regression analysis to identify predictors of recurrence, any vascular event, or death.
RESULTS: During a mean follow-up of 5.5 years, the annual rates of recurrent primary intracerebral hemorrhage, vascular events, and vascular death were 2.1% (95% CI, 1.4 to 3.3%), 5.9% (95% CI, 4.5 to 7.7%), and 3.2% (95% CI, 2.2 to 4.5%). Age of 65 years or older was the only predictor of a recurrence (hazard ratio [HR], 2.8; 95% CI, 1.3 to 6.1) and vascular death (HR, 3.7; 95% CI, 2.0 to 7.0). In addition to age, male sex predicted the occurrence of vascular events (HR, 1.8; 95% CI, 1.1 to 3.0). Use of anticoagulation after the index bleeding tripled the risk of hemorrhagic events (HR, 3.0; 95% CI, 1.3 to 7.2).
CONCLUSION: Patients who recovered from a primary intracerebral hemorrhage had a 2.1% to 5.9% annual rate of recurrence, vascular death, or vascular events. Age of 65 years or older more than doubled the risk of recurrence, vascular event, or death. The risk of vascular events in men was increased twofold.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12136058     DOI: 10.1212/wnl.59.2.205

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  40 in total

1.  Challenges and controversies in the medical management of primary and antithrombotic-related intracerebral hemorrhage.

Authors:  Michael Moussouttas
Journal:  Ther Adv Neurol Disord       Date:  2012-01       Impact factor: 6.570

Review 2.  Should a patient with primary intracerebral haemorrhage receive antiplatelet or anticoagulant therapy?

Authors:  Mushtaq Wani; Emma Nga; Ranjini Navaratnasingham
Journal:  BMJ       Date:  2005-08-20

3.  The risk of recurrent stroke after intracerebral haemorrhage.

Authors:  H C Hanger; T J Wilkinson; N Fayez-Iskander; R Sainsbury
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-01-12       Impact factor: 10.154

Review 4.  Should anticoagulation be resumed after intracerebral hemorrhage?

Authors:  Joshua N Goldstein; Steven M Greenberg
Journal:  Cleve Clin J Med       Date:  2010-11       Impact factor: 2.321

5.  Restarting oral anticoagulants after intracerebral hemorrhage: pros.

Authors:  George Ntaios
Journal:  Intern Emerg Med       Date:  2014-11-28       Impact factor: 3.397

6.  Management of acute intracerebral haemorrhage - an update.

Authors:  Zhe Kang Law; Jason P Appleton; Philip M Bath; Nikola Sprigg
Journal:  Clin Med (Lond)       Date:  2017-04       Impact factor: 2.659

Review 7.  Management of special conditions in patients on vitamin K antagonists.

Authors:  Francesco Marongiu; Guido Finazzi; Vittorio Pengo; Daniela Poli; Sophie Testa; Armando Tripodi
Journal:  Intern Emerg Med       Date:  2011-05-27       Impact factor: 3.397

8.  Ischemic Stroke and Bleeding: Clinical Benefit of Anticoagulation in Atrial Fibrillation After Intracerebral Hemorrhage.

Authors:  Robert J Stanton; Mark H Eckman; Daniel Woo; Charles J Moomaw; Mary Haverbusch; Matthew L Flaherty; Dawn O Kleindorfer
Journal:  Stroke       Date:  2020-01-31       Impact factor: 7.914

9.  Safety and efficacy of restarting antiplatelet therapy after intracerebral hemorrhage.

Authors:  Mi-Yeon Eun; Jin-Man Jung
Journal:  Ann Transl Med       Date:  2019-09

10.  Intracerebral hemorrhage: clinical overview and pathophysiologic concepts.

Authors:  Fred Rincon; Stephan A Mayer
Journal:  Transl Stroke Res       Date:  2012-04-21       Impact factor: 6.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.